Pacira BioSciences, Inc. announced preliminary net product sales results for August 2022. For the month, the company's net product sales were $59.1 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.21 USD | -0.40% | +3.34% | -19.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.35% | 1.27B | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira BioSciences, Inc. Announces Preliminary Net Product Sales Results for August 2022